Dynavax Technologies Corp (DVAX)
10.72
-0.28
(-2.59%)
USD |
NASDAQ |
May 10, 16:00
10.72
0.00 (0.00%)
After-Hours: 20:00
Dynavax Technologies Cash from Investing (Quarterly): -20.24M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -20.24M |
| September 30, 2023 | -106.07M |
| June 30, 2023 | 24.72M |
| March 31, 2023 | -52.33M |
| December 31, 2022 | -32.97M |
| September 30, 2022 | -119.05M |
| June 30, 2022 | 52.50M |
| March 31, 2022 | -216.48M |
| December 31, 2021 | 54.94M |
| September 30, 2021 | 45.67M |
| June 30, 2021 | -63.75M |
| March 31, 2021 | -22.63M |
| December 31, 2020 | 14.34M |
| September 30, 2020 | -2.054M |
| June 30, 2020 | -49.38M |
| March 31, 2020 | 10.56M |
| December 31, 2019 | 24.85M |
| September 30, 2019 | -40.22M |
| June 30, 2019 | -42.03M |
| March 31, 2019 | 14.61M |
| December 31, 2018 | 44.41M |
| September 30, 2018 | 43.56M |
| June 30, 2018 | 27.18M |
| March 31, 2018 | -59.68M |
| December 31, 2017 | 6.057M |
| Date | Value |
|---|---|
| September 30, 2017 | -82.35M |
| June 30, 2017 | -25.40M |
| March 31, 2017 | -7.011M |
| December 31, 2016 | 28.12M |
| September 30, 2016 | 25.98M |
| June 30, 2016 | 11.39M |
| March 31, 2016 | 20.75M |
| December 31, 2015 | -36.55M |
| September 30, 2015 | -63.51M |
| June 30, 2015 | 24.78M |
| March 31, 2015 | -10.52M |
| December 31, 2014 | 37.11M |
| September 30, 2014 | 25.86M |
| June 30, 2014 | 12.89M |
| March 31, 2014 | 14.73M |
| December 31, 2013 | -102.57M |
| September 30, 2013 | 6.66M |
| June 30, 2013 | 8.205M |
| March 31, 2013 | 36.35M |
| December 31, 2012 | 4.583M |
| September 30, 2012 | 1.442M |
| June 30, 2012 | -39.38M |
| March 31, 2012 | -6.343M |
| December 31, 2011 | -48.72M |
| September 30, 2011 | -0.335M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-216.48M
Minimum
Mar 2022
54.94M
Maximum
Dec 2021
-28.40M
Average
-22.63M
Median
Mar 2021
Cash from Investing (Quarterly) Benchmarks
| Supernus Pharmaceuticals Inc | -65.98M |
| Esperion Therapeutics Inc | 0.00 |
| Deciphera Pharmaceuticals Inc | 2.199M |
| ACADIA Pharmaceuticals Inc | -14.04M |
| Oragenics Inc | -1.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 13.77M |
| Cash from Financing (Quarterly) | 1.776M |
| Free Cash Flow | 96.46M |
| Free Cash Flow Per Share (Quarterly) | 0.0931 |
| Free Cash Flow to Equity (Quarterly) | 11.76M |
| Free Cash Flow to Firm (Quarterly) | 12.04M |
| Free Cash Flow Yield | 6.38% |